 |
The survival advantage appears to be linked to the use of non-selective beta-blockers Related items from OnMedica Beta blockers linked to lower dementia risk Be alert to ovarian cancer, MDU warns GPs HRT short-term use raises risk of ovarian cancer, warns study Blood test could boost early detection of ovarian cancer Experts disappointed at NICE decision on ovarian cancer drug |
Wednesday, 26 August 2015
Beta blockers appear to lengthen survival in ovarian cancer
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment